Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian P Wicks

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Nature Reviews. Rheumatology|December 4, 2015
Targeting GM-CSF in inflammatory diseasesIan P Wicks, Andrew W Roberts
Nature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John Silke
Current Pharmaceutical Design|March 12, 2015
Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedsideXiao Liu, Andrew J Teichtahl, Ian P Wicks
Trends in Molecular Medicine|July 11, 2020
Inflammasomes and Cell Death: Common Pathways in Microparticle DiseasesMaryam Rashidi, Ian P Wicks, James E Vince
Arthritis and Rheumatism|October 4, 2005
Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantationGeoffrey J McColl, Jeff Szer, Ian P Wicks
Immunology and Cell Biology|September 13, 2003
Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritisIan K Campbell, Lynden J Roberts, Ian P Wicks
The Medical Journal of Australia|February 27, 2004
Patient education and self-management programs in arthritisRichard H Osborne, Jean M Spinks, Ian P Wicks
Annals of the Rheumatic Diseases|May 31, 2020
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'Mandana Nikpour, Benjamin Teh, Ian P Wicks, et al.
Seminars in Arthritis and Rheumatism|August 20, 2013
Improving treatment with methotrexate in rheumatoid arthritis-development of a multimedia patient education program and the MiRAK, a new instrument to evaluate methotrexate-related knowledgeSabina Ciciriello, Rachelle Buchbinder, Richard H Osborne, et al.
The Medical Journal of Australia|March 22, 2006
Reducing the cardiovascular disease burden in rheumatoid arthritisSharon Van Doornum, Garry L R Jennings, Ian P Wicks
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Nature Reviews. Rheumatology|December 4, 2015
Targeting GM-CSF in inflammatory diseasesIan P Wicks, Andrew W Roberts
Nature Reviews. Rheumatology|July 10, 2020
Cell death in chronic inflammation: breaking the cycle to treat rheumatic diseaseHolly Anderton, Ian P Wicks, John Silke
Current Pharmaceutical Design|March 12, 2015
Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedsideXiao Liu, Andrew J Teichtahl, Ian P Wicks
Trends in Molecular Medicine|July 11, 2020
Inflammasomes and Cell Death: Common Pathways in Microparticle DiseasesMaryam Rashidi, Ian P Wicks, James E Vince
Arthritis and Rheumatism|October 4, 2005
Sustained remission, possibly cure, of seronegative arthritis after high-dose chemotherapy and syngeneic hematopoietic stem cell transplantationGeoffrey J McColl, Jeff Szer, Ian P Wicks
Immunology and Cell Biology|September 13, 2003
Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritisIan K Campbell, Lynden J Roberts, Ian P Wicks
The Medical Journal of Australia|February 27, 2004
Patient education and self-management programs in arthritisRichard H Osborne, Jean M Spinks, Ian P Wicks
Annals of the Rheumatic Diseases|May 31, 2020
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'Mandana Nikpour, Benjamin Teh, Ian P Wicks, et al.
Seminars in Arthritis and Rheumatism|August 20, 2013
Improving treatment with methotrexate in rheumatoid arthritis-development of a multimedia patient education program and the MiRAK, a new instrument to evaluate methotrexate-related knowledgeSabina Ciciriello, Rachelle Buchbinder, Richard H Osborne, et al.
The Medical Journal of Australia|March 22, 2006
Reducing the cardiovascular disease burden in rheumatoid arthritisSharon Van Doornum, Garry L R Jennings, Ian P Wicks
Pageof 11